C12Y 304/24013
Iga-specific metalloendopeptidase
Official title: IgA-specific metalloendopeptidase (3.4.24.13)
C12Y304/24013 (Iga-specific metalloendopeptidase) appears on 1 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 8
- Assignees
- 5
- Inventors
- 11
- Latest grant
- 15 Feb 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Truncated forms of iga protease, fusion proteins comprising a truncated form of iga protease and uses thereof31 Jul 2025US 2025/0242002 A1Peking University First Hospital
- Fusion proteins and methods for treating, preventing or ameliorating pain10 Oct 2019US 2019/0309277 A1Allergan, Inc.
- Suppression of itch18 Oct 2018US 2018/0298367 A1Ipsen Bioinnovation Limited
- Fusion proteins and methods for treating, preventing or ameliorating pain16 Nov 2017US 2017/0327810 A1Allergan, Inc.
- Suppression of itch19 May 2016US 2016/0137999 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.